CD276 and cancer: All samples demonstrated B7-H3 expression in both cancer cells and tumor vasculature, with 21 of 24 samples showing moderate or strong staining in ≥40% of cancer cells, and all samples demonstrated detectable B7-H3 expression in ≥70% of cancer cells.